Navigation Links
XTL Biopharmaceuticals Ltd. Extraordinary General Meetings Postponed Until March 18, 2009
Date:3/11/2009

VALLEY COTTAGE, N.Y., March 11 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB; TASE: XTL) announced today that its Extraordinary General Meetings ("EGMs") were postponed for one week in accordance with its articles of association due to the absence of a quorum. The postponed EGMs will take place at the Company, Building 3, Kiryat Weizmann Science Park, Rehovot, Israel 76100 at 3:00 p.m. and 5:30 p.m. Israel time on March 18, 2009.

Any proxy votes received at any time up to 48 hours prior to the postponed EGM will be included in the total votes counted for the EGMs. Those shareholders who have a valid "proof of ownership" in Israel or a letter of representation from Computershare, the Company's UK registrars, or a letter of representation from the Bank of NY for an ADR owner, and attend the meeting in person will also be permitted to vote.


'/>"/>
SOURCE XTL Biopharmaceuticals Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Keryx Biopharmaceuticals Inc. Announces Receipt of Nasdaq Delisting Notification
2. Frost & Sullivans Biopharmaceuticals Market Briefing to Address the Use of Embryonic Stem Cells
3. Eiger BioPharmaceuticals Raises $7.1 Million A Round
4. Mindset BioPharmaceuticals (USA) Inc Obtains Notice of Allowance for European Patent Related to Use of Insulin Sensitizers in Senile Dementia, Dementia and Memory Loss
5. XTL Biopharmaceuticals Announces Appointment of David Grossman and Boaz Shweiger to Board of Directors
6. Corrected: XTL Biopharmaceuticals to Convene Extraordinary Shareholders Meetings after Receipt of Shareholder Letter
7. XTL Biopharmaceuticals to Convene Extraordinary Shareholders Meetings after Receipt of Shareholder Letter
8. XTL Biopharmaceuticals Announces Receipt of NASDAQ Notice of Delisting
9. XTL Biopharmaceuticals Provides Update on Potential Strategic Alternatives
10. Keryx Biopharmaceuticals to Present at the J.P. Morgan 27th Annual Healthcare Conference
11. Johnson & Johnson Completes Acquisition of Omrix Biopharmaceuticals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... ... January 17, 2017 , ... MS Technologies™ and Bayer have ... Soybean Performance System will combine industry-leading genetics with a double herbicide-tolerant trait that ... Balance® Bean herbicide. The Balance™ GT Soybean Performance System will benefit soybean growers ...
(Date:1/17/2017)... 2017 The Global Implantable Biomaterials Market ... around 7.5% over the next decade to reach ... prominent trends that the market is witnessing include ... graft transplant surgeries and medical implants and technological ... categorized into immunomodulatory biomaterials, natural, polymers, hydrogels and ...
(Date:1/17/2017)...  An international team of researchers from UC ... Hospital Albrechtsen Research Centre/University of Manitoba have identified ... need affecting nearly one in 15 Americans. Published ... results identify small molecule drugs with neuroprotective and ... in animal models of metabolic, chemical and infection ...
(Date:1/17/2017)... N.J. , Jan. 17, 2017 Roka Bioscience, Inc. ... providing advanced testing solutions for the detection of foodborne pathogens today ... CEO.  Ms. Duseau succeeds Paul Thomas , the Company,s President ... of the Company,s Board of Directors.  The changes are effective today. ... of Directors, effective today. ...
Breaking Biology Technology:
(Date:12/8/2016)... -- Singulex, Inc., the leader in Next Generation Immunodiagnostics powered ... and supply agreement with Thermo Fisher Scientific, the world ... to Thermo Scientific BRAHMS PCT (Procalcitonin), a biomarker which, ... diagnose systemic bacterial infection and sepsis and in ... assessing the risk of critically ill patients for progression ...
(Date:12/7/2016)... LONDON , Dec. 7, 2016   Avanade ... most successful Formula One teams in history, exploit biometric ... pit stop performance and maintain the competitive edge against ... in 2016. Avanade has worked with ... a range of biometric data (heart rate, breathing rate, ...
(Date:12/6/2016)... , Dec. 6, 2016 Valencell , ... today it has seen a third consecutive year of ... sensor technology in 2016 with a 360 percent increase ... year. This increase was driven by sales of its ... robust interest in its technology for hearables for fitness ...
Breaking Biology News(10 mins):